Stay updated on Pembrolizumab & Blinatumomab in ALL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Blinatumomab in ALL Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a Locations section showing the California site and updated the page revision from v3.3.2 to v3.3.3. Removed the HHS Vulnerability Disclosure and the California Locations entry.
    Difference
    0.2%
    Check dated 2025-12-23T13:27:31.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is shown on the page, and Revision: v3.3.1 has been removed.
    Difference
    0.1%
    Check dated 2025-12-01T17:48:20.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added replacing v3.2.0, a minor site version update with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:44:44.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The government funding operating-status notice at the top was removed. Study details and navigation remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T07:15:09.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Administrative updates were made to the study record, including last update dates and QC criteria; no changes to the study design, eligibility criteria, primary or secondary outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:49.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    3%
    Check dated 2025-10-05T10:09:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Blinatumomab in ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.